Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Go back to Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
(NASDAQ: CRBU) Delayed: 1.64 --0 (-0%)
Previous Close $1.64    52 Week High
Open $1.63    52 Week Low
Day High $1.70    P/E N/A 
Day Low $1.62    EPS
Volume 1,771,097